Yongming Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yongming Jia has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Kexin Liu
Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China
5 shared publications - Zhihao Liu
Department of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA
4 shared publications - Changyuan Wang
Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China
3 shared publications Na Wang
Department of Neuropharmacology, College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China
3 shared publications- Xiaokui Huo
Pharmaceutical Research Center, Second Affiliated Hospital, Dalian Medical University, Dalian, China
3 shared publications Bo Zhang
Department of Neuroscience, Institute for Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China
2 shared publications
Latest Publications
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 3862342
Kai‐Xin‐San, a Chinese Herbal Decoction, Accelerates the Degradation of β‐Amyloid by Enhancing the Expression of Neprilysin in Rats
This study aimed to investigate the mechanisms of Kai‐Xin‐San (KXS, a famous Chinese herbal decoction used to treat amnesia) on the degradation of Aβ and further elucidate the mechanism of KXS on Aβ‐induced memory dysfunction. After pretreatment with KXS (1.08 g/kg/day) for two weeks, Aβ42 (2 μL, 200 μM) was injected into rat hippocampus to induce cognitive dysfunction. Morris water maze (MWM) test was developed to evaluate cognitive performance in rats. Hippocampal neurons were observed by histological staining using Hematoxylin‐Eosin (HE) methods. Levels of exogenous Aβ42, which was injected into the hippocampus, were continually measured through a special Enzyme‐linked immunoassay (ELISA) kit to observe the catabolic process of Aβ in the brain. Similarly, Aβ degradation in PC12 cells was also investigated using the ELISA kit. The expressions of Aβ degeneration enzymes, including neprilysin (NEP), angiotensin‐converting enzyme (ACE), and endothelin‐converting enzyme (ECE), were detected by western blotting to elucidate Aβ reduction mechanism. Our results showed that KXS prevented Aβ42‐induced cognitive impairment and attenuated hippocampus neuronal damage caused by Aβ42. Moreover, KXS could accelerate Aβ42 degradation in Aβ42 injected rats. Furthermore, NEP, an Aβ degradation enzyme, was increased in the hippocampus while ECE and ACE, other two Aβ‐degrading enzymes, were not changed. KXS accelerated Aβ degradation in PC12 cells. Our findings revealed that KXS facilitated the degradation of Aβ42 by increasing the expression of NEP in rat hippocampus. By reducing the Aβ burdens, KXS protected hippocampal neurons, leading to the improvement of cognitive function in rats.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 3862342
Open AccessKai‐Xin‐San, a Chinese Herbal Decoction, Accelerates the Degradation of β‐Amyloid by Enhancing the Expression of Neprilysin in Rats
This study aimed to investigate the mechanisms of Kai‐Xin‐San (KXS, a famous Chinese herbal decoction used to treat amnesia) on the degradation of Aβ and further elucidate the mechanism of KXS on Aβ‐induced memory dysfunction. After pretreatment with KXS (1.08 g/kg/day) for two weeks, Aβ42 (2 μL, 200 μM) was injected into rat hippocampus to induce cognitive dysfunction. Morris water maze (MWM) test was developed to evaluate cognitive performance in rats. Hippocampal neurons were observed by histological staining using Hematoxylin‐Eosin (HE) methods. Levels of exogenous Aβ42, which was injected into the hippocampus, were continually measured through a special Enzyme‐linked immunoassay (ELISA) kit to observe the catabolic process of Aβ in the brain. Similarly, Aβ degradation in PC12 cells was also investigated using the ELISA kit. The expressions of Aβ degeneration enzymes, including neprilysin (NEP), angiotensin‐converting enzyme (ACE), and endothelin‐converting enzyme (ECE), were detected by western blotting to elucidate Aβ reduction mechanism. Our results showed that KXS prevented Aβ42‐induced cognitive impairment and attenuated hippocampus neuronal damage caused by Aβ42. Moreover, KXS could accelerate Aβ42 degradation in Aβ42 injected rats. Furthermore, NEP, an Aβ degradation enzyme, was increased in the hippocampus while ECE and ACE, other two Aβ‐degrading enzymes, were not changed. KXS accelerated Aβ degradation in PC12 cells. Our findings revealed that KXS facilitated the degradation of Aβ42 by increasing the expression of NEP in rat hippocampus. By reducing the Aβ burdens, KXS protected hippocampal neurons, leading to the improvement of cognitive function in rats.
- 24 June 2019
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 42 (15-16) , 528-536
An environmentally friendly and green method for separation and determination of eight phenolic acids in raw and processed Tussilagofarfara L. by ultra-high performance supercritical fluid chromatography
Phenolic acid as an important active ingredient of traditional Chinese medicine, have received extensive attention due to its various biological activities and pharmacological effects. However, the presence of isomers makes the separation of phenolic acids challenging. In the present study an environmentally friendly, sustainable, lower cost, and green that reduce amounts of organic solventsultra-performance convergence chromatography (UPC2) method was developed for separation and quantification eight phenolic acids. Ultra-high performance supercritical fluid chromatography combines the advantages of supercritical fluid chromatography and ultra high performance liquid chromatography technologies with shorter analysis time, higher resolution and better environmental compatibility. The effects of different chromatographic column, co-solvent, column temperature and back pressure were studied. The BEH column was provided the most suitable separation withgradient elution in 20 min using CO2 as the mobile phase and methanol/acetonitrile (70/30, v/v) with 2% TFA as the co-solvent at a flow rate of 0.4 mL/min. A better and more symmetrical peak shape were obtained. Subsequently, the established method was applied to the quantification of phenolic acids in raw and processed Tussilago farfara L. and validated according to FDA guidelines, showed good precision, accuracy, repeatability and linearity in the concentration range. Our findings confirm that the method could be used as an efficient method for exploring phenolic acids of the quality and separation of traditional Chinese medicine. GRAPHICAL ABSTRACT
- 24 June 2019
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 42 (15-16) , 528-536
An environmentally friendly and green method for separation and determination of eight phenolic acids in raw and processed Tussilagofarfara L. by ultra-high performance supercritical fluid chromatography
Phenolic acid as an important active ingredient of traditional Chinese medicine, have received extensive attention due to its various biological activities and pharmacological effects. However, the presence of isomers makes the separation of phenolic acids challenging. In the present study an environmentally friendly, sustainable, lower cost, and green that reduce amounts of organic solventsultra-performance convergence chromatography (UPC2) method was developed for separation and quantification eight phenolic acids. Ultra-high performance supercritical fluid chromatography combines the advantages of supercritical fluid chromatography and ultra high performance liquid chromatography technologies with shorter analysis time, higher resolution and better environmental compatibility. The effects of different chromatographic column, co-solvent, column temperature and back pressure were studied. The BEH column was provided the most suitable separation withgradient elution in 20 min using CO2 as the mobile phase and methanol/acetonitrile (70/30, v/v) with 2% TFA as the co-solvent at a flow rate of 0.4 mL/min. A better and more symmetrical peak shape were obtained. Subsequently, the established method was applied to the quantification of phenolic acids in raw and processed Tussilago farfara L. and validated according to FDA guidelines, showed good precision, accuracy, repeatability and linearity in the concentration range. Our findings confirm that the method could be used as an efficient method for exploring phenolic acids of the quality and separation of traditional Chinese medicine. GRAPHICAL ABSTRACT
- Open Access
Resveratrol and Amyloid-Beta: Mechanistic Insights
The amyloid-beta (Aβ) hypothesis that dyshomeostasis between Aβ production and clearance is a very early, key molecular factor in the etiology of Alzheimer’s disease (AD) has been proposed and examined in the AD research field. Scientists have focused on seeking natural products or drugs to influence the dynamic equilibrium of Aβ, targeting production and clearance of Aβ. There is emerging evidence that resveratrol (Res), a naturally occurring polyphenol mainly found in grapes and red wine, acts on AD in numerous in vivo and in vitro models. Res decreases the amyloidogenic cleavage of the amyloid precursor protein (APP), enhances clearance of amyloid beta-peptides, and reduces Aβ aggregation. Moreover, Res also protects neuronal functions through its antioxidant properties. This review discusses the action of Res on Aβ production, clearance and aggregation and multiple potential mechanisms, providing evidence of the useful of Res for AD treatment.
Open AccessResveratrol and Amyloid-Beta: Mechanistic Insights
The amyloid-beta (Aβ) hypothesis that dyshomeostasis between Aβ production and clearance is a very early, key molecular factor in the etiology of Alzheimer’s disease (AD) has been proposed and examined in the AD research field. Scientists have focused on seeking natural products or drugs to influence the dynamic equilibrium of Aβ, targeting production and clearance of Aβ. There is emerging evidence that resveratrol (Res), a naturally occurring polyphenol mainly found in grapes and red wine, acts on AD in numerous in vivo and in vitro models. Res decreases the amyloidogenic cleavage of the amyloid precursor protein (APP), enhances clearance of amyloid beta-peptides, and reduces Aβ aggregation. Moreover, Res also protects neuronal functions through its antioxidant properties. This review discusses the action of Res on Aβ production, clearance and aggregation and multiple potential mechanisms, providing evidence of the useful of Res for AD treatment.
- Open Access
- 11 May 2017
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (41) , 25461-25468
Organic anion transporters 1 (OAT1) and OAT3 meditated the protective effect of rhein on methotrexate-induced nephrotoxicity
Rhein is identified as a major metabolite of diacerein, a prodrug used in the treatment of osteoarthritis. Methotrexate (MTX) is a highly toxic drug with a low therapeutic index. MTX and diacerein are used concomitantly in clinical practice for the treatment of rheumatoid arthritis. The purpose of this study was to investigate organic anion transporters (OAT)-mediated effect of rhein on the disposition of MTX, as well as to clarify the changes in nephrotoxicity of MTX when given rhein together. Concomitant administration of rhein could strongly increase the systemic exposure in rats. Similarly, MTX accumulation was markedly inhibited by rhein in rat kidney slices and hOAT1/3-HEK293 cell, indicating that OAT1 and OAT3 were involved in the drug–drug interaction (DDI) in the kidney. Additionally, concomitant administration of rhein attenuated cytotoxic effects of MTX in hOAT1/3-HEK293 cells, and alleviated nephrotoxicity caused by MTX in rats. In conclusion, rhein decreased renal elimination of MTX by inhibiting OAT1 and OAT3, and alleviated MTX-induced renal toxicity in vivo.
- 11 May 2017
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (41) , 25461-25468
Open AccessOrganic anion transporters 1 (OAT1) and OAT3 meditated the protective effect of rhein on methotrexate-induced nephrotoxicity
Rhein is identified as a major metabolite of diacerein, a prodrug used in the treatment of osteoarthritis. Methotrexate (MTX) is a highly toxic drug with a low therapeutic index. MTX and diacerein are used concomitantly in clinical practice for the treatment of rheumatoid arthritis. The purpose of this study was to investigate organic anion transporters (OAT)-mediated effect of rhein on the disposition of MTX, as well as to clarify the changes in nephrotoxicity of MTX when given rhein together. Concomitant administration of rhein could strongly increase the systemic exposure in rats. Similarly, MTX accumulation was markedly inhibited by rhein in rat kidney slices and hOAT1/3-HEK293 cell, indicating that OAT1 and OAT3 were involved in the drug–drug interaction (DDI) in the kidney. Additionally, concomitant administration of rhein attenuated cytotoxic effects of MTX in hOAT1/3-HEK293 cells, and alleviated nephrotoxicity caused by MTX in rats. In conclusion, rhein decreased renal elimination of MTX by inhibiting OAT1 and OAT3, and alleviated MTX-induced renal toxicity in vivo.
- Open Access
- 1 January 2017
- Published by Medknow in Neural Regeneration Research
- Vol. 12 (4) , 654-659
Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation
Kai Xin San is a Chinese herbal formula composed of Radix Ginseng , Poria , Radix Polygalae and Acorus Tatarinowii Rhizome . It has been used in China for many years for treating amnesia. Kai Xin San ameliorates amyloid-β (Aβ)-induced cognitive dysfunction and is neuroprotective in vivo , but its precise mechanism remains unclear. Expression of insulin-degrading enzyme (IDE), which degrades Aβ, is strongly correlated with cognitive function. Here, we injected rats with exogenous Aβ42 (200 μM, 5 μL) into the hippocampus and subsequently administered Kai Xin San (0.54 or 1.08 g/kg/d) intragastrically for 21 consecutive days. Hematoxylin-eosin and Nissl staining revealed that Kai Xin San protected neurons against Aβ-induced damage. Furthermore, enzyme-linked immunosorbent assay, western blot and polymerase chain reaction results showed that Kai Xin San decreased Aβ42 protein levels and increased expression of IDE protein, but not mRNA, in the hippocampus. Our findings reveal that Kai Xin San facilitates hippocampal Aβ degradation and increases IDE expression, which leads, at least in part, to the alleviation of hippocampal neuron injury in rats.
- 1 January 2017
- Published by Medknow in Neural Regeneration Research
- Vol. 12 (4) , 654-659
Open AccessNeuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation
Kai Xin San is a Chinese herbal formula composed of Radix Ginseng , Poria , Radix Polygalae and Acorus Tatarinowii Rhizome . It has been used in China for many years for treating amnesia. Kai Xin San ameliorates amyloid-β (Aβ)-induced cognitive dysfunction and is neuroprotective in vivo , but its precise mechanism remains unclear. Expression of insulin-degrading enzyme (IDE), which degrades Aβ, is strongly correlated with cognitive function. Here, we injected rats with exogenous Aβ42 (200 μM, 5 μL) into the hippocampus and subsequently administered Kai Xin San (0.54 or 1.08 g/kg/d) intragastrically for 21 consecutive days. Hematoxylin-eosin and Nissl staining revealed that Kai Xin San protected neurons against Aβ-induced damage. Furthermore, enzyme-linked immunosorbent assay, western blot and polymerase chain reaction results showed that Kai Xin San decreased Aβ42 protein levels and increased expression of IDE protein, but not mRNA, in the hippocampus. Our findings reveal that Kai Xin San facilitates hippocampal Aβ degradation and increases IDE expression, which leads, at least in part, to the alleviation of hippocampal neuron injury in rats.
- 1 September 2016
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 306, 27-35
P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate
- 1 September 2016
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 306, 27-35
P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate
- 1 August 2016
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 305, 127-135
Dioscin protects against ANIT–induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats
- 1 August 2016
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 305, 127-135
Dioscin protects against ANIT–induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats
- 1 June 2016
- Vol. 51 (6) , 860-5
[Progress in regulation of drug transporters and metabolic enzymes by resveratrol].
Drug transporters and metabolic enzymes are two major factors in the regulation of disposition of drug in the body. Interestingly, resveratrol, as a new star of anticancer drug, has a close relationship with transporters and metabolic enzymes. It is known that resveratrol can activate or inhibit the function of several transporters directly. Furthermore, the expression of several transporters was changed. Meanwhile, resveratrol is able to inhibit the function of metabolic enzymes (cytochrome P450, CYP450) and regulate the expression of metabolic enzymes. For this reason, when resveratrol is administrated in combination with other drugs, drug-drug interaction (DDI) should be considered. In this review, we summarize the distribution of transporters and metabolic enzymes in the body, the effect of resveratrol on transporters and metabolic enzymes as well as the drug-resveratrol interaction mediated by transporters and metabolic enzymes.
- 1 June 2016
- Vol. 51 (6) , 860-5
[Progress in regulation of drug transporters and metabolic enzymes by resveratrol].
Drug transporters and metabolic enzymes are two major factors in the regulation of disposition of drug in the body. Interestingly, resveratrol, as a new star of anticancer drug, has a close relationship with transporters and metabolic enzymes. It is known that resveratrol can activate or inhibit the function of several transporters directly. Furthermore, the expression of several transporters was changed. Meanwhile, resveratrol is able to inhibit the function of metabolic enzymes (cytochrome P450, CYP450) and regulate the expression of metabolic enzymes. For this reason, when resveratrol is administrated in combination with other drugs, drug-drug interaction (DDI) should be considered. In this review, we summarize the distribution of transporters and metabolic enzymes in the body, the effect of resveratrol on transporters and metabolic enzymes as well as the drug-resveratrol interaction mediated by transporters and metabolic enzymes.
- 1 November 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 495 (1) , 588-598
Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro
- 1 November 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 495 (1) , 588-598
Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro
- 13 October 2015
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 117 (5) , 1233-1239
Resveratrol Increases Anti‐Proliferative Activity of Bestatin Through Downregulating P‐Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells
Multidrug resistance (MDR) is a major obstacle in the clinical therapy of hematological malignancies. P‐glycoprotein (P‐gp) overexpression results in reduction of intracellular drug concentration with a consequence that the cytotoxicity of anti‐tumor drugs is decreased, which leads to MDR in K562/ADR cells. In this study, we found that resveratrol enhanced the anti‐proliferative activity of bestatin in K562/ADR cells. Co‐treatment with resveratrol, IC50 values of bestatin in K562/ADR cells significantly decreased and activation of caspase‐3 and caspase‐8 increased, which indicated that resveratrol potentiated bestatin‐induced apoptosis. Resveratrol increased the intracellular concentration of bestatin through inhibiting P‐gp function and downregulating P‐gp expression at mRNA and protein levels, which increased anti‐proliferative activity of bestatin in K562/ADR cells. Resveratrol decreased the phosphorylation of Akt and mTOR but did not affect the phosphorylations of JNK or ERK1/2. These results demonstrated that resveratrol could increase the anti‐proliferative activity of bestatin through downregulating P‐gp expression via suppressing the PI3K/Akt/mTOR signaling pathway. J. Cell. Biochem. 117: 1233–1239, 2016.
- 13 October 2015
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 117 (5) , 1233-1239
Resveratrol Increases Anti‐Proliferative Activity of Bestatin Through Downregulating P‐Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells
Multidrug resistance (MDR) is a major obstacle in the clinical therapy of hematological malignancies. P‐glycoprotein (P‐gp) overexpression results in reduction of intracellular drug concentration with a consequence that the cytotoxicity of anti‐tumor drugs is decreased, which leads to MDR in K562/ADR cells. In this study, we found that resveratrol enhanced the anti‐proliferative activity of bestatin in K562/ADR cells. Co‐treatment with resveratrol, IC50 values of bestatin in K562/ADR cells significantly decreased and activation of caspase‐3 and caspase‐8 increased, which indicated that resveratrol potentiated bestatin‐induced apoptosis. Resveratrol increased the intracellular concentration of bestatin through inhibiting P‐gp function and downregulating P‐gp expression at mRNA and protein levels, which increased anti‐proliferative activity of bestatin in K562/ADR cells. Resveratrol decreased the phosphorylation of Akt and mTOR but did not affect the phosphorylations of JNK or ERK1/2. These results demonstrated that resveratrol could increase the anti‐proliferative activity of bestatin through downregulating P‐gp expression via suppressing the PI3K/Akt/mTOR signaling pathway. J. Cell. Biochem. 117: 1233–1239, 2016.